Literature DB >> 17074846

The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens.

Rebecca M Thomas1, Richard W Titball, Petra C F Oyston, Kate Griffin, Emma Waters, Paul G Hitchen, Stephen L Michell, I Darren Grice, Jennifer C Wilson, Joann L Prior.   

Abstract

We have determined the sequence of the gene cluster encoding the O antigen in Francisella novicida and compared it to the previously reported O-antigen cluster in Francisella tularensis subsp. tularensis. Immunization with purified lipopolysaccharide (LPS) from F. tularensis subsp. tularensis or F. novicida protected against challenge with Francisella tularensis subsp. holarctica and F. novicida, respectively. The LPS from F. tularensis subsp. tularensis did not confer protection against challenge with F. novicida, and the LPS from F. novicida did not confer protection against challenge with F. tularensis subsp. holarctica. Allelic replacement mutants of F. tularensis subsp. tularensis or F. novicida which failed to produce O antigen were attenuated, but exposure to these mutants did not induce a protective immune response. The O antigen of F. tularensis subsp. tularensis appeared to be important for intracellular survival whereas the O antigen of F. novicida appeared to be critical for serum resistance and less important for intracellular survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074846      PMCID: PMC1828428          DOI: 10.1128/IAI.01241-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  EVALUATION OF LIVE TULAREMIA VACCINE PREPARED IN A CHEMICALLY DEFINED MEDIUM.

Authors:  R E CHAMBERLAIN
Journal:  Appl Microbiol       Date:  1965-03

2.  A new organism resembling P. tularensis isolated from water.

Authors:  C L LARSON; W WICHT; W L JELLISON
Journal:  Public Health Rep       Date:  1955-03       Impact factor: 2.792

3.  Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.

Authors:  H T EIGELSBACH; C M DOWNS
Journal:  J Immunol       Date:  1961-10       Impact factor: 5.422

4.  Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli.

Authors:  G BERTANI
Journal:  J Bacteriol       Date:  1951-09       Impact factor: 3.490

5.  Structural characterization of the cell surface lipooligosaccharides from a nontypable strain of Haemophilus influenzae.

Authors:  N J Phillips; M A Apicella; J M Griffiss; B W Gibson
Journal:  Biochemistry       Date:  1992-05-12       Impact factor: 3.162

6.  Evolution of subspecies of Francisella tularensis.

Authors:  Kerstin Svensson; Pär Larsson; Daniel Johansson; Mona Byström; Mats Forsman; Anders Johansson
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

7.  Genetic characterization of pilin glycosylation in Neisseria meningitidis.

Authors:  P M Power; L F Roddam; M Dieckelmann; Y N Srikhanta; Y C Tan; A W Berrington; M P Jennings
Journal:  Microbiology       Date:  2000-04       Impact factor: 2.777

8.  Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.

Authors:  M Fulop; P Mastroeni; M Green; R W Titball
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

9.  First isolation of Francisella tularensis subsp. tularensis in Europe.

Authors:  D Gurycová
Journal:  Eur J Epidemiol       Date:  1998-12       Impact factor: 8.082

10.  Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production.

Authors:  S C Cowley; S V Myltseva; F E Nano
Journal:  Mol Microbiol       Date:  1996-05       Impact factor: 3.501

View more
  54 in total

1.  Francisella novicida bacteremia after a near-drowning accident.

Authors:  Meghan Brett; Avanthi Doppalapudi; Laurel B Respicio-Kingry; Debra Myers; Brigitte Husband; Kerry Pollard; Paul Mead; Jeannine M Petersen; Cynthia J Whitener
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

2.  Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages.

Authors:  Stephen R Lindemann; Kaitian Peng; Matthew E Long; Jason R Hunt; Michael A Apicella; Denise M Monack; Lee-Ann H Allen; Bradley D Jones
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.

Authors:  Qingmei Jia; Bai-Yu Lee; Richard Bowen; Barbara Jane Dillon; Susan M Som; Marcus A Horwitz
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

4.  O-antigen-deficient Francisella tularensis Live Vaccine Strain mutants are ingested via an aberrant form of looping phagocytosis and show altered kinetics of intracellular trafficking in human macrophages.

Authors:  Daniel L Clemens; Bai-Yu Lee; Marcus A Horwitz
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

5.  Outsmarting the host: bacteria modulating the immune response.

Authors:  Matthew D Woolard; Jeffrey A Frelinger
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  The Protease Locus of Francisella tularensis LVS Is Required for Stress Tolerance and Infection in the Mammalian Host.

Authors:  Lihong He; Manoj Kumar Mohan Nair; Yuling Chen; Xue Liu; Mengyun Zhang; Karsten R O Hazlett; Haiteng Deng; Jing-Ren Zhang
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

7.  AR-13, a Celecoxib Derivative, Directly Kills Francisella In Vitro and Aids Clearance and Mouse Survival In Vivo.

Authors:  Ky V Hoang; Haley E Adcox; James R Fitch; David M Gordon; Heather M Curry; Larry S Schlesinger; Peter White; John S Gunn
Journal:  Front Microbiol       Date:  2017-09-11       Impact factor: 5.640

8.  Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens.

Authors:  Robin Ireland; Norma Olivares-Zavaleta; Jonathan M Warawa; Frank C Gherardini; Clayton Jarrett; B Joseph Hinnebusch; John T Belisle; Jeffery Fairman; Catharine M Bosio
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

9.  Azithromycin effectiveness against intracellular infections of Francisella.

Authors:  Saira Ahmad; Lyman Hunter; Aiping Qin; Barbara J Mann; Monique L van Hoek
Journal:  BMC Microbiol       Date:  2010-04-23       Impact factor: 3.605

10.  The type IV pilin, PilA, is required for full virulence of Francisella tularensis subspecies tularensis.

Authors:  Anna-Lena Forslund; Emelie Näslund Salomonsson; Igor Golovliov; Kerstin Kuoppa; Stephen Michell; Richard Titball; Petra Oyston; Laila Noppa; Anders Sjöstedt; Ake Forsberg
Journal:  BMC Microbiol       Date:  2010-08-26       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.